Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)

Market Cap	1.12B
Revenue (ttm)	920.59M
Net Income (ttm)	108.51M
Shares Out	n/a
EPS (ttm)	0.11
PE Ratio	10.35
Forward PE	8.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Average Volume	3,141
Open	1.140
Previous Close	1.090
Day's Range	1.140 - 1.140
52-Week Range	0.931 - 1.430
Beta	0.48
RSI	54.94
Earnings Date	Jul 23, 2025

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,665
• Stock Exchange: OTCMKTS
• Ticker Symbol: GNMLF

Financial Performance

In 2024, Genomma Lab Internacional's revenue was 18.61 billion, an increase of 12.99% compared to the previous year's 16.47 billion. Earnings were 2.09 billion, an increase of 92.74%.

Financial numbers in MXN